It has been observed that a number of NRGs, including DNASE1, HMGB1 and PIK3CA, undergo gains in SCNV across a variety of cancer types, which was consistent with previous studies (Lin et al., 2011; Ueki et al., 2019; Martell et al., 2020). Here, DNASE1 is linked to cancer.